| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.08 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.09 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |